Senate panel to examine blood substitute study

02/24/2006 | Wall Street Journal, The

Sen. Charles E. Grassley, R-Iowa, chairman of the Senate Finance Committee, is questioning Northfield Laboratories' and the FDA's actions regarding a 720-patient trauma study of a blood substitute. Grassley is looking into whether patients were aware of potential side effects and the full results of a previous study on PolyHeme.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA